If a product has an outer and inner packaging, the list of ingredients can only appear on the outer packaging. The list of ingredients may appear on the information panels (side walls of the package). Cosmetics that may be dangerous to consumers if misused must be accompanied by appropriate warnings and instructions for safe use. Statements must be prominent and visible. Certain cosmetic products must carry warnings or warnings prescribed by the Regulations (21 CFR 740). Examples of products that require such declarations include cosmetics in self-pressed containers (aerosol products), feminine deodorant sprays and bubble bath products for children. It should be noted that until the conclusion of the determination that the identity of a cosmetic ingredient is a trade secret has been completed, the cosmetic product in question cannot be labelled “and other ingredients” instead of a statement of identity of the ingredient for which confidentiality has been requested. The phrase “and other ingredients” cannot be used on the label until an ingredient has been accepted by the FDA as exempt from disclosure, or if confidentiality has been denied, if a lawsuit is filed within 30 days of a final decision that the ingredient in question is not a trade secret. 1. Proprietary mixtures of ingredients identified in the list of ingredients by a “(and)” in parentheses are often declared on the label, as indicated in the section of the dictionary that lists chemical or trade names and their respective label names. The compounds in these mixtures must be separated, the “(and)” omitted and the constituents treated as individual ingredients for labelling purposes. See “Mica (and) titanium dioxide (and) iron oxides”. 2.

A mail order business must immediately send a copy of an ingredient declaration to any person who so requests. Panel Display: The required information must be on a panel that is presented or displayed under the usual purchase conditions. This eliminates the placement of the required information on a background of a cosmetic, unless it is very small and is usually taken by hand, where it is checked for a possible purchase. Accompanying ingredients do not need to be declared on the label. Section 509 of the fd&c act provides that the categories “medicines” and “cosmetics” are not mutually exclusive. The PDP of a “boudoir type” or decorative cosmetic container, such as a cartridge, pill box, compact or special variety, and those containing 1/4 oz or less, may be a label or detachable adhesive tape attached to the container [21 CFR 701.13(e)(1)]. It may also be the bulletin board of a card on which the immediate container is attached [21 CFR 701.13(e)(2)]. If the product contains a cosmetic ingredient that does not present sufficient evidence of safety, the cosmetic label must contain the warning: As in the EU, the ingredients must be listed in descending order of dominance.

Ingredients with a concentration of less than 1% can be listed in any order after listing ingredients of more than 1%. The following information is essential if you comply with the ingredient labeling guidelines for the information display panel of a cosmetic label: The active ingredient aluminum chlorohydrate is identified as an “active ingredient” in accordance with Section 502(e) of the FD&C Act. The remaining ingredients may be labelled as “cosmetic ingredients” as directed or as “other ingredients”. The first step is to understand how your individual products are ranked. If something is designed to treat or prevent a disease, it is classified as a drug. (These include personal care products such as sunscreens, antibacterial soap, and hand sanitizers.) Although these are also cosmetic products, the information panel must comply with pharmaceutical labeling regulations, not FDA cosmetics regulations. Ingredients must be listed with their INCI names, and like the EU, Canada also accepts the words “fragrance” or “aroma” for fragrances or flavors. Botanical ingredients must be listed at least by genus and species names or using the full inci name. On the left side, the ingredients are listed in descending order of supremacy in accordance with § 701.3 (2). Location: If the cosmetic is sold at retail in an outer container, the indication of the net content (1) must appear in the bottom 30% of the PDP of the outer container, usually parallel to the base on which the packaging rests, and (2) on an information panel of the inner container.

The lower site requirement is waived for PDPs of 5 square inches or less. Decorative cosmetics sold in the United States can also share a list of ingredients between shades in the same product line. In this case, each grade has the same list of ingredients, in which the dyes must be listed and the end of the list of ingredients and after the phrase “may contain”. The following information is an overview of the regulatory requirements for cosmetics, with a focus on those that affect labelling. A cosmetic is also legally a drug if it is intended to exert both a physical and physiological effect, since the FD&C Law of Article 201(g) defines the term “drug” to, among other things, “items that are intended for use in the. Cure, mitigate, treat or prevent diseases. and. Article.

intends to affect the structure or any function of the body… » a conventional declaration of ingredients in which the constituents of each product are identified under the corresponding headings, listing either all ingredients in descending order of their dominant position in accordance with § 701.3 letter a, or ingredients in accordance with § 701.3 letter f, ingredients other than those present in concentrations greater than 1% are first indicated in descending order, followed by non-colour constituents present in concentrations of 1 % or less, in any order; followed by the coloring additives present in any concentration, or on the left side, two conventional ingredient declarations are displayed, each representing a hue.